Banque Cantonale Vaudoise’s bluebird bio BLUE Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27	Closed	-$2K	–	1238
2022 Q2	$2K	Hold	27	–	–	﹤0.01%	1249
2022 Q1	$3K	Sell	27 -47	-64%	-$6.2K	﹤0.01%	1255
2021 Q4	$15K	Sell	74 -48	-39%	-$11.3K	﹤0.01%	1211
2021 Q3	$30K	Sell	122 -5	-4%	-$1.43K	﹤0.01%	1113
2021 Q2	$52K	Hold	127	–	–	﹤0.01%	1036
2021 Q1	$49K	Sell	127 -2	-2%	-$985	﹤0.01%	1002
2020 Q4	$72K	Sell	129 -3	-2%	-$1.9K	﹤0.01%	892
2020 Q3	$92K	Hold	132	–	–	0.01%	839
2020 Q2	$104K	Sell	132 -4	-3%	-$3.02K	0.01%	774
2020 Q1	$81K	Sell	136 -206	-60%	-$201K	0.01%	794
2019 Q4	$389K	Buy	+342	New	+$372K	0.03%	546

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Banque Cantonale Vaudoise's BLUE Position: Q3 2022 in Review

Banque Cantonale Vaudoise sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 27 shares — an estimated $2K sold.

Banque Cantonale Vaudoise first reported a position in BLUE in Q4 2019 and held it in 11 quarters. The position peaked at $389K in Q4 2019. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

Banque Cantonale Vaudoise reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
Banque Cantonale Vaudoise sold 27 bluebird bio shares in Q3 2022, an estimated $2K.
Banque Cantonale Vaudoise first reported a position in bluebird bio in Q4 2019 and held it in 11 quarters.
Banque Cantonale Vaudoise's bluebird bio position peaked at $389K in Q4 2019.
162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2022, filed 17 Oct 2022.